MCID: PRT031
MIFTS: 17

Parotid Disease

Categories: Oral diseases

Aliases & Classifications for Parotid Disease

MalaCards integrated aliases for Parotid Disease:

Name: Parotid Disease 12 15
Parotid Diseases 44 73

Classifications:



External Ids:

Disease Ontology 12 DOID:10302
MeSH 44 D010305
UMLS 73 C0030579

Summaries for Parotid Disease

MalaCards based summary : Parotid Disease, also known as parotid diseases, is related to parotitis and viral infectious disease. An important gene associated with Parotid Disease is HSF4 (Heat Shock Transcription Factor 4). The drugs Immunologic Factors and Vaccines have been mentioned in the context of this disorder.

Related Diseases for Parotid Disease

Diseases related to Parotid Disease via text searches within MalaCards or GeneCards Suite gene sharing:

# Related Disease Score Top Affiliating Genes
1 parotitis 11.0
2 viral infectious disease 9.8
3 panniculitis 9.6
4 squamous cell carcinoma 9.6
5 lupus erythematosus 9.6
6 lupus erythematosus panniculitis 9.6

Graphical network of the top 20 diseases related to Parotid Disease:



Diseases related to Parotid Disease

Symptoms & Phenotypes for Parotid Disease

Drugs & Therapeutics for Parotid Disease

Drugs for Parotid Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 24)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1 Immunologic Factors Phase 4,Phase 3,Phase 2,Phase 1
2 Vaccines Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
3 Heptavalent Pneumococcal Conjugate Vaccine Phase 3
4
Bevacizumab Approved, Investigational Phase 1 216974-75-3
5
Cisplatin Approved Phase 1 15663-27-1 2767 441203 84093
6
Docetaxel Approved, Investigational Phase 1 114977-28-5 148124
7 Angiogenesis Modulating Agents Phase 1
8
Erlotinib Hydrochloride Phase 1 183319-69-9 176871
9 Protein Kinase Inhibitors Phase 1
10 Antimitotic Agents Phase 1
11 Angiogenesis Inhibitors Phase 1
12
Morphine Approved, Investigational Not Applicable 57-27-2 5288826
13
Citric Acid Approved, Nutraceutical, Vet_approved Not Applicable 77-92-9 311
14 Analgesics Not Applicable
15 Narcotics Not Applicable
16 Central Nervous System Depressants Not Applicable
17 Peripheral Nervous System Agents Not Applicable
18 Analgesics, Opioid Not Applicable
19 Calcium, Dietary Not Applicable
20 Anticoagulants Not Applicable
21 Citrate Not Applicable
22 Chelating Agents Not Applicable
23 Antibodies
24 Immunoglobulins

Interventional clinical trials:

(show all 36)
# Name Status NCT ID Phase Drugs
1 Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella Vaccine Completed NCT02880865 Phase 4
2 Comparative Study of the Immunogenicity of MMR (Measles, Mumps and Rubella) Single Dose and Multidose Presentations Completed NCT01777529 Phase 4
3 Immunogenicity and Safety of Hepatitis A Vaccine Given at the Same Time of Measles, Mumps, Rubella Combined Vaccine Completed NCT00313950 Phase 4
4 Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases Completed NCT00126997 Phase 4
5 Intensity-Modulated Radiation Therapy or 3-Dimensional Conformal Radiation Therapy in Decreasing Hearing Loss in Patients Who Have Undergone Surgery for Parotid Tumors Unknown status NCT01216800 Phase 3
6 Safety and Immunogenicity Study of Live Attenuated Mumps Vaccines in Healthy Infants Completed NCT02692599 Phase 3
7 Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of Age Completed NCT02184572 Phase 3
8 Immunogenicity and Safety of GSK Biologicals' Combined Measles-mumps-rubella Vaccine in Volunteers, Seven Years of Age and Older Completed NCT02058563 Phase 3
9 Study of Immunogenicity, Reactogenicity and Safety of the Combined Measles, Mumps and Rubella Vaccine Produced by Bio-Manguinhos/Fiocruz in Children 12-15 Months of Age, Followed by Tetraviral Vaccine in Children 15-18 Months. Completed NCT01991899 Phase 3
10 Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of Life Completed NCT01681992 Phase 3
11 Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of Age Completed NCT01621802 Phase 3
12 Safety, Tolerability, and Immunogenicity of Measles, Mumps, Rubella, and Varicella (MMRV) Vaccine Made With an Alternative Manufacturing Process (AMP)(V221-027) Completed NCT01536405 Phase 3
13 The Use of Human Acellular Dermal Matrix to Improve Infraauricular Depressed Deformities and Frey's Syndrome Completed NCT01414790 Phase 3
14 Study of Japanese Encephalitis Chimeric Virus Vaccine Given With Measles-Mumps-Rubella Vaccine in Taiwanese Toddlers Completed NCT01188343 Phase 3
15 Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTM Completed NCT00969436 Phase 3
16 Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136 Completed NCT00751348 Phase 3
17 Long-term Follow-up on Immunogenicity & Safety of Measles-Mumps-Rubella-Varicella (MMRV) Combined Vaccine Completed NCT00406211 Phase 3
18 Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases Completed NCT00127023 Phase 3
19 Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases Completed NCT00127010 Phase 3
20 Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine (V221-016) Completed NCT00092430 Phase 3
21 A Study of An Approved Vaccine at Mumps Expiry Potency in Healthy Children 12 to 18 Months of Age (V205C-007)(COMPLETED) Completed NCT00092391 Phase 3
22 Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™ Completed NCT00353288 Phase 2
23 Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™ Completed NCT00352898 Phase 2
24 Phase II of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Chinese Infants Active, not recruiting NCT03133923 Phase 2
25 A Phase I, Safety Study of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Chinese Children Completed NCT01712906 Phase 1
26 Phase I of Biologics and Chemoradiation Therapy for Advanced Head and Neck Cancer Completed NCT00405405 Phase 1 Cisplatin;Docetaxel;Bevacizumab;Erlotinib
27 Gender and Opioid Consumption Unknown status NCT03006627 Not Applicable postoperative morphine
28 Feasibility Study of MRI Imaging on Parotid Gland Stimulation Unknown status NCT02294838 Not Applicable
29 Diagnostic Accuracy of Fine Needle Aspiration in Parotid Tumors Unknown status NCT00534612 Early Phase 1
30 Evaluation of Safety and Effectiveness of the FMwand Ferromagnetic Surgical System During Parotidectomy Surgery Completed NCT02291939
31 Post-parotidectomy Facial Paresis: Intraoperative and Postoperative Factors Completed NCT02527226 Not Applicable
32 Retrospective Clinical Outcome of Parotid Tumor Surgery Completed NCT01983176
33 Serological Study in Children 12 to 23 Months Vaccinated With MMR (Measles, Mumps and Rubella) Completed NCT01874457
34 Making Decisions About the Measles-Mumps-Rubella Vaccine Completed NCT01369394 Not Applicable
35 Measles, Mumps, and Rubella (MMR) Immunity in College Students Completed NCT00962819
36 Safety Study of Measles-Mumps-Rubella-Varicella (MMRV) Vaccine, Priorix-Tetra™ in Children Living in the Philippines Withdrawn NCT01738841

Search NIH Clinical Center for Parotid Disease

Cochrane evidence based reviews: parotid diseases

Genetic Tests for Parotid Disease

Anatomical Context for Parotid Disease

Publications for Parotid Disease

Articles related to Parotid Disease:

(show all 26)
# Title Authors Year
1
Quality of life following surgical treatment of benign parotid disease. ( 24427625 )
2013
2
The diagnosis and management of parotid disease. ( 23159219 )
2013
3
Evaluation of superficial musculoaponeurotic system flap and fat graft outcomes for benign and malignant parotid disease. ( 23358951 )
2013
4
Polycystic parotid disease in a male child: report of a case and review of the literature. ( 21256652 )
2011
5
Predictors of facial palsy after surgery for benign parotid disease: multivariate analysis of 626 operations. ( 19536764 )
2009
6
Analysis of complications following surgical treatment of benign parotid disease. ( 18269474 )
2008
7
Parotidectomy for benign parotid disease at a university teaching hospital: outcome of 963 operations. ( 16585855 )
2006
8
Extent of parotid disease influences outcome in patients with metastatic cutaneous squamous cell carcinoma. ( 12874077 )
2003
9
The role of imaging in the evaluation of parotid disease. ( 12169280 )
2002
10
Surgical management of parotid disease. ( 11709975 )
2000
11
Surgical management of chronic parotid disease. ( 11092780 )
2000
12
Surgical management of parotid disease. ( 11905347 )
1998
13
Periparotid lupus erythematosus panniculitis. Clinicopathologic correlation of two cases presenting as primary parotid disease. ( 8489346 )
1993
14
Surgical treatment in non-neoplastic parotid disease: indications and results. ( 1393876 )
1992
15
Parotid disease and human immunodeficiency virus infection in Zambia. ( 1393467 )
1992
16
Polycystic parotid disease: a case report. ( 1941341 )
1991
17
Parotid disease associated with human immunodeficiency virus infection. ( 2401224 )
1990
18
Diagnostic techniques for parotid disease. ( 2945579 )
1986
19
A comparative analysis of the clinical, sialographic, and pathologic findings in parotid disease. ( 4062061 )
1985
20
Benign parotid diseases of childhood. ( 4021684 )
1985
21
Surgical parotid disease in Nigeria: a review of 100 cases. ( 6589340 )
1984
22
Diagnostic ultrasound imaging of parotid disease--a contemporary clinical perspective. ( 6471159 )
1984
23
Historical and pathological curiosities of parotid disease. ( 4665891 )
1972
24
Surgery and facial nerve grafting in malignant parotid disease. ( 4315450 )
1970
25
Surgery for nonneoplastic parotid disease. ( 5506056 )
1970
26
Surgical management of benign parotid disease. ( 5337252 )
1967

Variations for Parotid Disease

Expression for Parotid Disease

Search GEO for disease gene expression data for Parotid Disease.

Pathways for Parotid Disease

GO Terms for Parotid Disease

Biological processes related to Parotid Disease according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cell death GO:0008219 8.62 MAP3K9 NUP62

Sources for Parotid Disease

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....